- Conditions
- Bronchopulmonary Dysplasia
- Interventions
- Minimally invasive surfactant therapy, Continuation on CPAP
- Device · Other
- Lead sponsor
- Menzies Institute for Medical Research
- Other
- Eligibility
- 1 Minute to 6 Hours
- Enrollment
- 486 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2022
- U.S. locations
- 5
- States / cities
- New Haven, Connecticut • Honolulu, Hawaii • Evanston, Illinois + 2 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–12
of 12
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Respiratory Distress Syndrome, Newborn
- Interventions
- CHF5633, Poractant alfa
- Drug
- Lead sponsor
- Chiesi Farmaceutici S.p.A.
- Industry
- Eligibility
- 1 Hour to 24 Hours
- Enrollment
- 123 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2018
- U.S. locations
- 23
- States / cities
- Mobile, Alabama • Los Angeles, California • Orange, California + 20 more
- Conditions
- Respiratory Distress Syndrome
- Interventions
- Poractant alfa, calfactant
- Drug
- Lead sponsor
- University of Missouri-Columbia
- Other
- Eligibility
- 22 Weeks to 35 Weeks
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2015
- U.S. locations
- 1
- States / cities
- Columbia, Missouri
- Conditions
- Respiratory Distress Syndrome (RDS)
- Interventions
- LISA combination product (Curosurf+catheter CHF6440), Curosurf through conventional administration (endotracheal tube)
- Combination Product · Drug
- Lead sponsor
- Chiesi Farmaceutici S.p.A.
- Industry
- Eligibility
- 30 Minutes to 24 Hours
- Enrollment
- 33 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2022
- U.S. locations
- 26
- States / cities
- Little Rock, Arkansas • Los Angeles, California • Denver, Colorado + 22 more
- Conditions
- Respiratory Distress Syndrome
- Interventions
- MIST surfactant
- Drug
- Lead sponsor
- Endeavor Health
- Other
- Eligibility
- Up to 48 Hours
- Enrollment
- 262 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2027
- U.S. locations
- 1
- States / cities
- Evanston, Illinois
- Conditions
- Prematurity, Respiratory Distress Syndrome, Patent Ductus Arteriosus
- Interventions
- Survanta (beractant), Curosurf (poractant)
- Drug
- Lead sponsor
- Alan Fujii
- Other
- Eligibility
- Up to 8 Hours
- Enrollment
- 52 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2009
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Respiratory Distress Syndrome, Newborn, Premature Birth
- Interventions
- Poractant Alfa
- Drug
- Lead sponsor
- Endeavor Health
- Other
- Eligibility
- Up to 15 Minutes
- Enrollment
- 200 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2027
- U.S. locations
- 1
- States / cities
- Evanston, Illinois
- Conditions
- Acute Respiratory Distress Syndrome
- Interventions
- CUROSURF® (poractant alfa)
- Drug
- Lead sponsor
- Chiesi Farmaceutici S.p.A.
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 22 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2022
- U.S. locations
- 1
- States / cities
- Detroit, Michigan
- Conditions
- Extreme Prematurity, Respiratory Distress Syndrome
- Interventions
- LISA
- Procedure
- Lead sponsor
- University of Texas Southwestern Medical Center
- Other
- Eligibility
- 5 Minutes to 20 Minutes
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2025
- U.S. locations
- 1
- States / cities
- Dallas, Texas
- Conditions
- Congenital Heart Disease, Hypoplastic Left Heart Syndrome
- Interventions
- Curosurf, Sham
- Drug
- Lead sponsor
- University of Michigan
- Other
- Eligibility
- 1 Day to 12 Weeks
- Enrollment
- 2 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020
- U.S. locations
- 1
- States / cities
- Ann Arbor, Michigan
- Conditions
- Respiratory Distress Syndrome
- Interventions
- Curosurf®, Survanta®
- Drug
- Lead sponsor
- University of Michigan
- Other
- Eligibility
- 15 Minutes to 12 Hours
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2012
- U.S. locations
- 1
- States / cities
- Ann Arbor, Michigan
- Conditions
- Bronchopulmonary Dysplasia (BPD), Respiratory Distress Syndrome, Prematurity; Extreme, Neonatal
- Interventions
- budesonide (Pulmicort nebulizing suspension)., surfactant (poractant alfa;Curosurf)
- Drug
- Lead sponsor
- NICHD Neonatal Research Network
- Network
- Eligibility
- Up to 48 Hours
- Enrollment
- 642 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2026
- U.S. locations
- 19
- States / cities
- Birmingham, Alabama • Palo Alto, California • San Diego, California + 15 more